Nature Reviews Clinical Oncology

Vol. 23, Issue 3 Issue 3 2026
10
Articles

Articles in this Issue

Author Correction: Advances in the management of localized bladder cancers

Marie-Pier St-Laurent, Jussi Nikkola, Eisuke Tomiyama et al. Mar 01, 2026 pp. 230-230 10.1038/s41571-026-01121-6

A guide to cancer screening

Stephen W. Duffy, Judith Offman Mar 01, 2026 pp. 201-212 10.1038/s41571-025-01112-z

Base-edited CAR7 T cells are safe and efficacious in R/R T-ALL

Diana Romero Mar 01, 2026 pp. 152-152 10.1038/s41571-025-01118-7

Discovery of predictive biomarkers for cancer therapy through computational approaches

Xin Wang, Julia Nguyen, Kristen Nader et al. Mar 01, 2026 pp. 180-200 10.1038/s41571-025-01109-8

The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology

Amber Johnson, Yifei Shen, Xiaofeng Zheng et al. Mar 01, 2026 pp. 213-229 10.1038/s41571-025-01110-1

Advances in the management of localized bladder cancers

Marie-Pier St-Laurent, Jussi Nikkola, Eisuke Tomiyama et al. Mar 01, 2026 pp. 158-179 10.1038/s41571-025-01104-z

Vebreltinib effective in MET-amplified NSCLC

Peter Sidaway Mar 01, 2026 pp. 151-151 10.1038/s41571-025-01117-8

MajesTEC results with teclistamab in relapsed and/or refractory multiple myeloma

David Killock Mar 01, 2026 pp. 151-151 10.1038/s41571-025-01116-9

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer

Britt B. M. Suelmann, Michiel S. Van Der Heijden Mar 01, 2026 pp. 155-156 10.1038/s41571-025-01113-y

When ctDNA says ‘maybe’: improving the dynamics of MRD trials

Julien Taieb Mar 01, 2026 pp. 153-154 10.1038/s41571-025-01111-0

All Issues

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page